The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
The Opioid Epidemic: From Evidence to Impact
EXECUTIVE SUMMARY While prescription opioids serve an invaluable role for the treatment of cancer pain and pain at the end of life, their overuse for acute and chronic non-cancer pain as well as the increasing availability of heroin and...
Beyond Beds: The Vital Role of a Full Continuum of Psychiatric Care
Summary Nearly 10 million individuals in the United States are estimated to live with a diagnosable psychiatric condition sufficiently serious to impair their personal, social and economic functioning. Hardly a day goes by without a study...
Determining Counselling Communication Strategies Associated with Successful Quits in the 'Stop Smoking Programme' in East London
Abstract Objectives: To determine communication strategies associated with smoking cessation in the National Health Service community pharmacy Stop Smoking programme. Setting: 11 community pharmacies in three inner east London boroughs...
Cognitive Complexity of Clients and Counsellors during Motivation-Based Treatment for Smoking Cessation
Abstract Objective: Motivational interviewing (MI) is a widely used and promising treatment approach for aiding in smoking cessation. The present observational study adds to other recent research on why and when MI works by investigating a...
Regressive or Progressive? The Effect of Tobacco Taxes in Ukraine
ABSTRACT Tobacco taxes are usually considered regressive as the poorest individuals allocate larger shares of their budget towards the purchase of tobacco related products. However, because these taxes also discourage tobacco use, some of...
Ending the Opioid Crisis: A Practical Guide for State Policymakers
BACKGROUND Although the opioid epidemic is a national issue, states shoulder the majority of the financial and social burden caused by addiction. Fortunately, there are many actions that states can take to effectively address the opioid...
Licit and Illicit Substance Use Patterns among University Students in Germany Using Cluster Analysis
Abstract Background The use of multiple licit and illicit substances plays an important role in many university students’ lives. Previous research on multiple substance use patterns of university students, however, often fails to examine...
Efficacy and Safety of Cannabinoid Oromucosal Spray for Multiple Sclerosis Spasticity
Abstract Background: The approval of 9-δ-tetrahydocannabinol and cannabidiol (THC:CBD) oromucosal spray (Sativex) for the management of treatment-resistant multiple sclerosis (MS) spasticity opened a new opportunity for many patients. The...
The Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence
Key Points Question: Are monthly intramuscular injections with extended-release naltrexone hydrochloride as effective as daily oral buprenorphine–naloxone hydrochloride in reducing the use of heroin and other illicit substances in newly...
Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas — United States
Abstract Problem/Condition: Drug overdoses are a leading cause of injury death in the United States, resulting in approximately 52,000 deaths in 2015. Understanding differences in illicit drug use, illicit drug use disorders, and overall...